Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edith M Hessel

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Nature|July 10, 2024
In situ targeted base editing of bacteria in the mouse gutAndreas K Brödel, Loïc H Charpenay, Matthieu Galtier, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 4, 2019
Translation of Inhaled Drug Optimization Strategies into Clinical Pharmacokinetics and Pharmacodynamics Using GSK2292767A, a Novel Inhaled Phosphoinositide 3-Kinase <i>δ</i> InhibitorMalcolm Begg, Chris D Edwards, J Nicole Hamblin, et al.
DNA and Cell Biology|February 9, 2005
Superior activity of the type C class of ISS in vitro and in vivo across multiple speciesJason D Marshall, Karen L Fearon, Debbie Higgins, et al.
Thorax|January 25, 2019
Use of autologous <sup>99m</sup>Technetium-labelled neutrophils to quantify lung neutrophil clearance in COPDNicola Tregay, Malcolm Begg, Anthony Cahn, et al.
International Journal of Chronic Obstructive Pulmonary Disease|June 11, 2021
Exploring PI3Kδ Molecular Pathways in Stable COPD and Following an Acute Exacerbation, Two Randomized Controlled TrialsMalcolm Begg, J Nicole Hamblin, Emily Jarvis, et al.
Journal of Medicinal Chemistry|December 20, 2019
Optimization of Orally Bioavailable PI3Kδ Inhibitors and Identification of Vps34 as a Key Selectivity TargetZoë A Henley, Augustin Amour, Nick Barton, et al.
Nature Communications|December 15, 2019
Obesity and disease severity magnify disturbed microbiome-immune interactions in asthma patientsDavid Michalovich, Noelia Rodriguez-Perez, Sylwia Smolinska, et al.
American Journal of Respiratory Cell and Molecular Biology|May 1, 2024
The FAM13A Long Isoform Regulates Cilia Movement and Coordination in Airway Mucociliary TransportAshleigh Howes, Clare Rogerson, Nikolai Belyaev, et al.
Science Translational Medicine|May 27, 2026
Treatment of Shiga toxin-producing <i>E. coli</i> infection by CRISPR-Cas-targeted cleavage of the Shiga toxin gene in animal modelsMatthieu Galtier, Antonina Krawczyk, Fabien J Fuche, et al.
Journal of Medicinal Chemistry|September 13, 2021
Discovery of GSK251: A Highly Potent, Highly Selective, Orally Bioavailable Inhibitor of PI3Kδ with a Novel Binding ModeKenneth Down, Augustin Amour, Niall A Anderson, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Nature|July 10, 2024
In situ targeted base editing of bacteria in the mouse gutAndreas K Brödel, Loïc H Charpenay, Matthieu Galtier, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 4, 2019
Translation of Inhaled Drug Optimization Strategies into Clinical Pharmacokinetics and Pharmacodynamics Using GSK2292767A, a Novel Inhaled Phosphoinositide 3-Kinase <i>δ</i> InhibitorMalcolm Begg, Chris D Edwards, J Nicole Hamblin, et al.
DNA and Cell Biology|February 9, 2005
Superior activity of the type C class of ISS in vitro and in vivo across multiple speciesJason D Marshall, Karen L Fearon, Debbie Higgins, et al.
Thorax|January 25, 2019
Use of autologous <sup>99m</sup>Technetium-labelled neutrophils to quantify lung neutrophil clearance in COPDNicola Tregay, Malcolm Begg, Anthony Cahn, et al.
International Journal of Chronic Obstructive Pulmonary Disease|June 11, 2021
Exploring PI3Kδ Molecular Pathways in Stable COPD and Following an Acute Exacerbation, Two Randomized Controlled TrialsMalcolm Begg, J Nicole Hamblin, Emily Jarvis, et al.
Journal of Medicinal Chemistry|December 20, 2019
Optimization of Orally Bioavailable PI3Kδ Inhibitors and Identification of Vps34 as a Key Selectivity TargetZoë A Henley, Augustin Amour, Nick Barton, et al.
Nature Communications|December 15, 2019
Obesity and disease severity magnify disturbed microbiome-immune interactions in asthma patientsDavid Michalovich, Noelia Rodriguez-Perez, Sylwia Smolinska, et al.
American Journal of Respiratory Cell and Molecular Biology|May 1, 2024
The FAM13A Long Isoform Regulates Cilia Movement and Coordination in Airway Mucociliary TransportAshleigh Howes, Clare Rogerson, Nikolai Belyaev, et al.
Science Translational Medicine|May 27, 2026
Treatment of Shiga toxin-producing <i>E. coli</i> infection by CRISPR-Cas-targeted cleavage of the Shiga toxin gene in animal modelsMatthieu Galtier, Antonina Krawczyk, Fabien J Fuche, et al.
Journal of Medicinal Chemistry|September 13, 2021
Discovery of GSK251: A Highly Potent, Highly Selective, Orally Bioavailable Inhibitor of PI3Kδ with a Novel Binding ModeKenneth Down, Augustin Amour, Niall A Anderson, et al.
Pageof 6